Analysis	O
of	O
a	O
Mouse	B:C1519352
Skin	I:C1519352
Model	O
of	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
.	O

Analysis	O
of	O
a	O
Mouse	O
Skin	I:C1519352
Model	B:C2986594
of	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
.	O

Analysis	O
of	O
a	O
Mouse	O
Skin	I:C1519352
Model	O
of	O
Tuberous	B:C0041341
Sclerosis	I:C0041341
Complex	I:C0041341
.	O

Tuberous	B:C0041341
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	O
dominant	O
tumor	O
suppressor	I:C0079427
gene	I:C0079427
syndrome	O
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	O
,	O
including	O
facial	O
angiofibroma	I:C0265319
,	O
subungual	O
fibroma	I:C0266003
,	O
Shagreen	O
patch	I:C0432363
,	O
angiomyolipomas	O
,	O
and	O
lymphangioleiomyomatosis	O
.	O

Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	B:C0041341
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	O
dominant	O
tumor	O
suppressor	I:C0079427
gene	I:C0079427
syndrome	O
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	O
,	O
including	O
facial	O
angiofibroma	I:C0265319
,	O
subungual	O
fibroma	I:C0266003
,	O
Shagreen	O
patch	I:C0432363
,	O
angiomyolipomas	O
,	O
and	O
lymphangioleiomyomatosis	O
.	O

Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	B:C0596142
dominant	O
tumor	O
suppressor	I:C0079427
gene	I:C0079427
syndrome	O
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	O
,	O
including	O
facial	O
angiofibroma	I:C0265319
,	O
subungual	O
fibroma	I:C0266003
,	O
Shagreen	O
patch	I:C0432363
,	O
angiomyolipomas	O
,	O
and	O
lymphangioleiomyomatosis	O
.	O

Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	O
dominant	O
tumor	B:C0079427
suppressor	I:C0079427
gene	I:C0079427
syndrome	O
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	O
,	O
including	O
facial	O
angiofibroma	I:C0265319
,	O
subungual	O
fibroma	I:C0266003
,	O
Shagreen	O
patch	I:C0432363
,	O
angiomyolipomas	O
,	O
and	O
lymphangioleiomyomatosis	O
.	O

Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	O
dominant	O
tumor	O
suppressor	I:C0079427
gene	I:C0079427
syndrome	B:C0039082
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	O
,	O
including	O
facial	O
angiofibroma	I:C0265319
,	O
subungual	O
fibroma	I:C0266003
,	O
Shagreen	O
patch	I:C0432363
,	O
angiomyolipomas	O
,	O
and	O
lymphangioleiomyomatosis	O
.	O

Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	O
dominant	O
tumor	O
suppressor	I:C0079427
gene	I:C0079427
syndrome	O
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	B:C0027651
,	O
including	O
facial	O
angiofibroma	I:C0265319
,	O
subungual	O
fibroma	I:C0266003
,	O
Shagreen	O
patch	I:C0432363
,	O
angiomyolipomas	O
,	O
and	O
lymphangioleiomyomatosis	O
.	O

Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	O
dominant	O
tumor	O
suppressor	I:C0079427
gene	I:C0079427
syndrome	O
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	O
,	O
including	O
facial	B:C0265319
angiofibroma	I:C0265319
,	O
subungual	O
fibroma	I:C0266003
,	O
Shagreen	O
patch	I:C0432363
,	O
angiomyolipomas	O
,	O
and	O
lymphangioleiomyomatosis	O
.	O

Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	O
dominant	O
tumor	O
suppressor	I:C0079427
gene	I:C0079427
syndrome	O
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	O
,	O
including	O
facial	O
angiofibroma	I:C0265319
,	O
subungual	B:C0266003
fibroma	I:C0266003
,	O
Shagreen	O
patch	I:C0432363
,	O
angiomyolipomas	O
,	O
and	O
lymphangioleiomyomatosis	O
.	O

Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	O
dominant	O
tumor	O
suppressor	I:C0079427
gene	I:C0079427
syndrome	O
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	O
,	O
including	O
facial	O
angiofibroma	I:C0265319
,	O
subungual	O
fibroma	I:C0266003
,	O
Shagreen	B:C0432363
patch	I:C0432363
,	O
angiomyolipomas	O
,	O
and	O
lymphangioleiomyomatosis	O
.	O

Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	O
dominant	O
tumor	O
suppressor	I:C0079427
gene	I:C0079427
syndrome	O
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	O
,	O
including	O
facial	O
angiofibroma	I:C0265319
,	O
subungual	O
fibroma	I:C0266003
,	O
Shagreen	O
patch	I:C0432363
,	O
angiomyolipomas	B:C0206633
,	O
and	O
lymphangioleiomyomatosis	O
.	O

Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
(	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
)	O
is	O
an	O
autosomal	O
dominant	O
tumor	O
suppressor	I:C0079427
gene	I:C0079427
syndrome	O
in	O
which	O
patients	O
develop	O
several	O
types	O
of	O
tumors	O
,	O
including	O
facial	O
angiofibroma	I:C0265319
,	O
subungual	O
fibroma	I:C0266003
,	O
Shagreen	O
patch	I:C0432363
,	O
angiomyolipomas	O
,	O
and	O
lymphangioleiomyomatosis	B:C0751674
.	O

It	O
is	O
due	O
to	O
inactivating	O
mutations	B:C0596611
in	O
TSC1	O
or	O
TSC2	O
.	O

It	O
is	O
due	O
to	O
inactivating	O
mutations	O
in	O
TSC1	B:C0694894
or	O
TSC2	O
.	O

It	O
is	O
due	O
to	O
inactivating	O
mutations	O
in	O
TSC1	O
or	O
TSC2	B:C0694895
.	O

We	O
sought	O
to	O
generate	O
a	O
mouse	B:C2986594
model	I:C2986594
of	O
one	O
or	O
more	O
of	O
these	O
tumor	O
types	O
by	O
targeting	O
deletion	O
of	O
the	O
Tsc1	O
gene	I:C0694894
to	O
fibroblasts	O
using	O
the	O
Fsp	O
-	I:C1511573
Cre	I:C1511573
allele	O
.	O

We	O
sought	O
to	O
generate	O
a	O
mouse	O
model	I:C2986594
of	O
one	O
or	O
more	O
of	O
these	O
tumor	B:C0027651
types	O
by	O
targeting	O
deletion	O
of	O
the	O
Tsc1	O
gene	I:C0694894
to	O
fibroblasts	O
using	O
the	O
Fsp	O
-	I:C1511573
Cre	I:C1511573
allele	O
.	O

We	O
sought	O
to	O
generate	O
a	O
mouse	O
model	I:C2986594
of	O
one	O
or	O
more	O
of	O
these	O
tumor	O
types	O
by	O
targeting	O
deletion	B:C0017260
of	O
the	O
Tsc1	O
gene	I:C0694894
to	O
fibroblasts	O
using	O
the	O
Fsp	O
-	I:C1511573
Cre	I:C1511573
allele	O
.	O

We	O
sought	O
to	O
generate	O
a	O
mouse	O
model	I:C2986594
of	O
one	O
or	O
more	O
of	O
these	O
tumor	O
types	O
by	O
targeting	O
deletion	O
of	O
the	O
Tsc1	B:C0694894
gene	I:C0694894
to	O
fibroblasts	O
using	O
the	O
Fsp	O
-	I:C1511573
Cre	I:C1511573
allele	O
.	O

We	O
sought	O
to	O
generate	O
a	O
mouse	O
model	I:C2986594
of	O
one	O
or	O
more	O
of	O
these	O
tumor	O
types	O
by	O
targeting	O
deletion	O
of	O
the	O
Tsc1	O
gene	I:C0694894
to	O
fibroblasts	B:C0016030
using	O
the	O
Fsp	O
-	I:C1511573
Cre	I:C1511573
allele	O
.	O

We	O
sought	O
to	O
generate	O
a	O
mouse	O
model	I:C2986594
of	O
one	O
or	O
more	O
of	O
these	O
tumor	O
types	O
by	O
targeting	O
deletion	O
of	O
the	O
Tsc1	O
gene	I:C0694894
to	O
fibroblasts	O
using	O
the	O
Fsp	B:C1511573
-	I:C1511573
Cre	I:C1511573
allele	O
.	O

We	O
sought	O
to	O
generate	O
a	O
mouse	O
model	I:C2986594
of	O
one	O
or	O
more	O
of	O
these	O
tumor	O
types	O
by	O
targeting	O
deletion	O
of	O
the	O
Tsc1	O
gene	I:C0694894
to	O
fibroblasts	O
using	O
the	O
Fsp	O
-	I:C1511573
Cre	I:C1511573
allele	B:C0002085
.	O

Mutant	B:C0678941
,	O
Tsc1ccFsp	O
-	I:C0678941
Cre+	I:C0678941
mice	O
survived	O
a	O
median	O
of	O
nearly	O
a	O
year	O
,	O
and	O
developed	O
tumors	O
in	O
multiple	O
sites	O
but	O
did	O
not	I:C1513916
develop	I:C1513916
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Mutant	O
,	O
Tsc1ccFsp	B:C0678941
-	I:C0678941
Cre+	I:C0678941
mice	O
survived	O
a	O
median	O
of	O
nearly	O
a	O
year	O
,	O
and	O
developed	O
tumors	O
in	O
multiple	O
sites	O
but	O
did	O
not	I:C1513916
develop	I:C1513916
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Mutant	O
,	O
Tsc1ccFsp	O
-	I:C0678941
Cre+	I:C0678941
mice	B:C0025929
survived	O
a	O
median	O
of	O
nearly	O
a	O
year	O
,	O
and	O
developed	O
tumors	O
in	O
multiple	O
sites	O
but	O
did	O
not	I:C1513916
develop	I:C1513916
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Mutant	O
,	O
Tsc1ccFsp	O
-	I:C0678941
Cre+	I:C0678941
mice	O
survived	O
a	O
median	O
of	O
nearly	O
a	O
year	O
,	O
and	O
developed	O
tumors	B:C0027651
in	O
multiple	O
sites	O
but	O
did	O
not	I:C1513916
develop	I:C1513916
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Mutant	O
,	O
Tsc1ccFsp	O
-	I:C0678941
Cre+	I:C0678941
mice	O
survived	O
a	O
median	O
of	O
nearly	O
a	O
year	O
,	O
and	O
developed	O
tumors	O
in	O
multiple	O
sites	B:C0205145
but	O
did	O
not	I:C1513916
develop	I:C1513916
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Mutant	O
,	O
Tsc1ccFsp	O
-	I:C0678941
Cre+	I:C0678941
mice	O
survived	O
a	O
median	O
of	O
nearly	O
a	O
year	O
,	O
and	O
developed	O
tumors	O
in	O
multiple	O
sites	O
but	O
did	B:C1513916
not	I:C1513916
develop	I:C1513916
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Mutant	O
,	O
Tsc1ccFsp	O
-	I:C0678941
Cre+	I:C0678941
mice	O
survived	O
a	O
median	O
of	O
nearly	O
a	O
year	O
,	O
and	O
developed	O
tumors	O
in	O
multiple	O
sites	O
but	O
did	O
not	I:C1513916
develop	I:C1513916
angiomyolipoma	B:C0206633
or	O
lymphangioleiomyomatosis	O
.	O

Mutant	O
,	O
Tsc1ccFsp	O
-	I:C0678941
Cre+	I:C0678941
mice	O
survived	O
a	O
median	O
of	O
nearly	O
a	O
year	O
,	O
and	O
developed	O
tumors	O
in	O
multiple	O
sites	O
but	O
did	O
not	I:C1513916
develop	I:C1513916
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	B:C0751674
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	B:C1123023
phenotype	O
with	O
marked	O
thickening	O
of	O
the	O
dermis	O
with	O
accumulation	O
of	O
mast	O
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	O
therapy	O
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	O
seen	O
in	O
human	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
skin	O
lesions	I:C0037284
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	O
phenotype	O
with	O
marked	O
thickening	B:C0205400
of	O
the	O
dermis	O
with	O
accumulation	O
of	O
mast	O
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	O
therapy	O
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	O
seen	O
in	O
human	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
skin	O
lesions	I:C0037284
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	O
phenotype	O
with	O
marked	O
thickening	O
of	O
the	O
dermis	B:C0011646
with	O
accumulation	O
of	O
mast	O
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	O
therapy	O
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	O
seen	O
in	O
human	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
skin	O
lesions	I:C0037284
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	O
phenotype	O
with	O
marked	O
thickening	O
of	O
the	O
dermis	O
with	O
accumulation	B:C4055506
of	O
mast	O
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	O
therapy	O
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	O
seen	O
in	O
human	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
skin	O
lesions	I:C0037284
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	O
phenotype	O
with	O
marked	O
thickening	O
of	O
the	O
dermis	O
with	O
accumulation	O
of	O
mast	B:C0024880
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	O
therapy	O
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	O
seen	O
in	O
human	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
skin	O
lesions	I:C0037284
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	O
phenotype	O
with	O
marked	O
thickening	O
of	O
the	O
dermis	O
with	O
accumulation	O
of	O
mast	O
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	B:C0072980
therapy	O
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	O
seen	O
in	O
human	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
skin	O
lesions	I:C0037284
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	O
phenotype	O
with	O
marked	O
thickening	O
of	O
the	O
dermis	O
with	O
accumulation	O
of	O
mast	O
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	O
therapy	B:C0087111
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	O
seen	O
in	O
human	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
skin	O
lesions	I:C0037284
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	O
phenotype	O
with	O
marked	O
thickening	O
of	O
the	O
dermis	O
with	O
accumulation	O
of	O
mast	O
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	O
therapy	O
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	B:C0677042
seen	O
in	O
human	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
skin	O
lesions	I:C0037284
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	O
phenotype	O
with	O
marked	O
thickening	O
of	O
the	O
dermis	O
with	O
accumulation	O
of	O
mast	O
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	O
therapy	O
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	O
seen	O
in	O
human	B:C0086418
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
skin	O
lesions	I:C0037284
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	O
phenotype	O
with	O
marked	O
thickening	O
of	O
the	O
dermis	O
with	O
accumulation	O
of	O
mast	O
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	O
therapy	O
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	O
seen	O
in	O
human	O
Tuberous	B:C0041341
Sclerosis	I:C0041341
Complex	I:C0041341
skin	O
lesions	I:C0037284
.	O

They	O
did	O
develop	O
a	O
prominent	O
skin	O
phenotype	O
with	O
marked	O
thickening	O
of	O
the	O
dermis	O
with	O
accumulation	O
of	O
mast	O
cells	I:C0024880
,	O
that	O
was	O
minimally	O
responsive	O
to	O
systemic	O
rapamycin	O
therapy	O
,	O
and	O
was	O
quite	O
different	O
from	O
the	O
pathology	O
seen	O
in	O
human	O
Tuberous	O
Sclerosis	I:C0041341
Complex	I:C0041341
skin	B:C0037284
lesions	I:C0037284
.	O

Recombination	B:C0034865
and	O
loss	O
of	O
Tsc1	O
was	O
demonstrated	O
in	O
skin	O
fibroblasts	I:C1272578
in	O
vivo	I:C1515655
and	O
in	O
cultured	O
skin	O
fibroblasts	I:C1272578
.	O

Recombination	O
and	O
loss	O
of	O
Tsc1	B:C0694894
was	O
demonstrated	O
in	O
skin	O
fibroblasts	I:C1272578
in	O
vivo	I:C1515655
and	O
in	O
cultured	O
skin	O
fibroblasts	I:C1272578
.	O

Recombination	O
and	O
loss	O
of	O
Tsc1	O
was	O
demonstrated	O
in	O
skin	B:C1272578
fibroblasts	I:C1272578
in	O
vivo	I:C1515655
and	O
in	O
cultured	O
skin	O
fibroblasts	I:C1272578
.	O

Recombination	O
and	O
loss	O
of	O
Tsc1	O
was	O
demonstrated	O
in	O
skin	O
fibroblasts	I:C1272578
in	B:C1515655
vivo	I:C1515655
and	O
in	O
cultured	O
skin	O
fibroblasts	I:C1272578
.	O

Recombination	O
and	O
loss	O
of	O
Tsc1	O
was	O
demonstrated	O
in	O
skin	O
fibroblasts	I:C1272578
in	O
vivo	I:C1515655
and	O
in	O
cultured	B:C0007600
skin	O
fibroblasts	I:C1272578
.	O

Recombination	O
and	O
loss	O
of	O
Tsc1	O
was	O
demonstrated	O
in	O
skin	O
fibroblasts	I:C1272578
in	O
vivo	I:C1515655
and	O
in	O
cultured	O
skin	B:C1272578
fibroblasts	I:C1272578
.	O

Loss	O
of	O
Tsc1	B:C0694894
in	O
fibroblasts	O
in	O
mice	O
does	O
not	I:C1513916
lead	I:C1513916
to	O
a	O
model	O
of	O
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Loss	O
of	O
Tsc1	O
in	O
fibroblasts	B:C0016030
in	O
mice	O
does	O
not	I:C1513916
lead	I:C1513916
to	O
a	O
model	O
of	O
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Loss	O
of	O
Tsc1	O
in	O
fibroblasts	O
in	O
mice	B:C0025929
does	O
not	I:C1513916
lead	I:C1513916
to	O
a	O
model	O
of	O
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Loss	O
of	O
Tsc1	O
in	O
fibroblasts	O
in	O
mice	O
does	B:C1513916
not	I:C1513916
lead	I:C1513916
to	O
a	O
model	O
of	O
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Loss	O
of	O
Tsc1	O
in	O
fibroblasts	O
in	O
mice	O
does	O
not	I:C1513916
lead	I:C1513916
to	O
a	O
model	B:C2986594
of	O
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	O
.	O

Loss	O
of	O
Tsc1	O
in	O
fibroblasts	O
in	O
mice	O
does	O
not	I:C1513916
lead	I:C1513916
to	O
a	O
model	O
of	O
angiomyolipoma	B:C0206633
or	O
lymphangioleiomyomatosis	O
.	O

Loss	O
of	O
Tsc1	O
in	O
fibroblasts	O
in	O
mice	O
does	O
not	I:C1513916
lead	I:C1513916
to	O
a	O
model	O
of	O
angiomyolipoma	O
or	O
lymphangioleiomyomatosis	B:C0751674
.	O

